|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03880 MEDTIDE
Nominal 
18.530 -1.390 (-6.978%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 234,518 | -7.585% | 570,087 | 442,226 | 336,774 | 350,840 |
| Cost of Sales | (98,550) | -0.266% | (208,477) | (192,452) | (156,603) | (149,771) |
| Gross Profit | 135,968 | -12.253% | 361,610 | 249,774 | 180,171 | 201,069 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (1,313) | -- | 17,076 | (84,308) | (45,971) | (68,190) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 62,949 | -45.582% | 250,745 | 78,449 | 61,978 | 67,556 | |
| Taxation | (9,272) | -32.212% | (33,374) | (19,276) | (13,073) | (13,576) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 53,677 | -47.375% | 217,371 | 59,173 | 48,905 | 53,980 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (12,701) | 57.035% | (23,307) | (12,419) | (6,696) | 367 |
| Depreciation & Amortisation | 8,738 | -2.857% | 29,330 | 30,089 | 29,781 | 25,933 |
| Directors' Emoluments | -- | -- | -- | 13,335 | 3,857 | 4,304 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 38.000 | -53.659% | 163.000 | 47.000 | 39.000 | 54.000 |
| DPS (cts) | 0.000 | -- | 0.000 | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 2.003 | 0.964 | 0.707 | 1.342 |
| NBV per share ($) | 11.540 | -- | 11.176 | -- | -- | -- |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 53,677 |
| %Change | -47.375% |
| EPS / (LPS) | RMB 0.380 |
| NBV Per Share (¥) | RMB 11.540 |